THE DEAL, AT A GLANCE

Enveda

3/4 reviewed

EnvedaEnveda announced a $311 million Series E financing on September 23, 2026.

01Who is involvedCatalio led the Series E; new and existing investors also participated.Source-grounded · automated review · Explore ↗

Checked 2026-10-04 · Review due 2026-10-11

Read supporting source ↗

The funding was led by…

02What happenedEnveda announced a $311 million Series E financing on September 23, 2026.Source-grounded · automated review · Explore ↗

Checked 2026-10-04 · Review due 2026-10-11

Read supporting source ↗

Enveda has raised a $311…

03Why it mattersThe financing supports later-stage clinical testing of Enveda’s drug candidates.Interpretation · Explore ↗

Checked 2026-10-04 · Review due 2026-10-11

Read supporting source ↗

This financing is focused on…

Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗

Enveda · Financing Record

Explore source-linked visual explanations for Enveda. Unsupported claims are withheld while source review continues.

Record 12671 · Recorded date: 2026-09-23